On September 20, 2019, Robert J. Jakobs and Heat Biologics, Inc. entered into a Separation Agreement, which agreement will be effective on September 27, 2019, providing for, among other things, termination of Mr. Jakobs' employment as the company's Vice President of Finance. Mr. Jakobs last day of employment with the company was September 20, 2019. Effective September 25, 2019, the company has appointed William L. Ostrander to serve as the company's Vice President of Finance and Secretary. Mr. Ostrander most recently served as the Executive Director of Finance at Liquidia Technologies, Inc. from November 2014 until joining the company.